-transparent.png){kind=logo}
It was shown that mouse antiserum against isologous thermically aggregated immunoglobulins MAAS injected repeatedly to the animals prolonged the survival of the skin allotransplant, induced Moloney's sarcoma diminished the latent period of the tumour development sharply increased the formation of the tumours which in the majority of cases, led to the death of mice, deranged the normal age barrier in fibrosarcoma induction, and sharply inhibited the intensity of Rauscher's leukemia development. This action of MAAS on the transplantation and antitumour immunity was of immunological nature.
Related Publications
D R Kaulen, and
A E Snegireva, and
V V Khorobrykh, and
V Ia Shevliagin, and
O S Prigoda
December 1977,
Biulleten' eksperimental'noi biologii i meditsiny,
D R Kaulen, and
A E Snegireva, and
V V Khorobrykh, and
V Ia Shevliagin, and
O S Prigoda
July 1980,
Biulleten' eksperimental'noi biologii i meditsiny,
D R Kaulen, and
A E Snegireva, and
V V Khorobrykh, and
V Ia Shevliagin, and
O S Prigoda
May 1978,
Biulleten' eksperimental'noi biologii i meditsiny,
D R Kaulen, and
A E Snegireva, and
V V Khorobrykh, and
V Ia Shevliagin, and
O S Prigoda
November 1979,
Biulleten' eksperimental'noi biologii i meditsiny,
D R Kaulen, and
A E Snegireva, and
V V Khorobrykh, and
V Ia Shevliagin, and
O S Prigoda
January 1978,
Doklady Akademii nauk SSSR,
D R Kaulen, and
A E Snegireva, and
V V Khorobrykh, and
V Ia Shevliagin, and
O S Prigoda
April 1981,
Biulleten' eksperimental'noi biologii i meditsiny,
D R Kaulen, and
A E Snegireva, and
V V Khorobrykh, and
V Ia Shevliagin, and
O S Prigoda
July 1960,
Immunology,
D R Kaulen, and
A E Snegireva, and
V V Khorobrykh, and
V Ia Shevliagin, and
O S Prigoda
January 1978,
Ontogenez,
D R Kaulen, and
A E Snegireva, and
V V Khorobrykh, and
V Ia Shevliagin, and
O S Prigoda
March 1977,
Journal of the National Cancer Institute,
D R Kaulen, and
A E Snegireva, and
V V Khorobrykh, and
V Ia Shevliagin, and
O S Prigoda
December 1974,
Bulletin of experimental biology and medicine,
